Your search returned 5 results.

Results
	1.	Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors: Swain, Sandra M PMID: 28398846 Year: 2017 Citation: Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G DOI: https://dx.doi.org/10.1200/JCO.2016.71.4147 Add to cart (remove)
	2.	Reply to a. Avan et Al. MedStar authors: Swain, Sandra M PMID: 25870094 Year: 2015 Citation: Journal of Clinical Oncology. 33(15):1712, 2015 May 20. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Baselga J, Clark E, Kiermaier A, Swain S DOI: http://dx.doi.org/10.1200/JCO.2015.60.8398 Add to cart (remove)
	3.	Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25332247 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM DOI: http://dx.doi.org/10.1200/JCO.2013.54.5384 Add to cart (remove)
	4.	Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors: Swain, Sandra M PMID: 25332249 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA DOI: http://dx.doi.org/10.1200/JCO.2014.55.5730 Add to cart (remove)
	5.	What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?. MedStar authors: Whitaker, Kristen PMID: 38776577 Year: 2024 Citation: Journal of Surgical Research. 299:217-223, 2024 Jul. Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Forester E, Belsare A, Kim DW, Whitaker K, Obeid E, Goldstein LJ, Bleicher RJ, Daly MB, Williams AD DOI: https://dx.doi.org/10.1016/j.jss.2024.04.032 Add to cart (remove)

Powered by Koha